Aiman Shabbir’s Post

On Rare Disease day read our new publication on the power of the genomic MDT approach. Bringing improved diagnosis to patients, https://lnkd.in/eRQGFbMy

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐔𝐬𝐞 𝐁𝐚𝐬𝐞 𝐄𝐝𝐢𝐭𝐢𝐧𝐠 𝐭𝐨 𝐂𝐫𝐞𝐚𝐭𝐞 𝐭𝐡𝐞 𝐌𝐨𝐬𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐌𝐚𝐩 𝐘𝐞𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐇𝐮𝐦𝐚𝐧 𝐈𝐦𝐦𝐮𝐧𝐞 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞 The most detailed map of how human immune cells function has been published by researchers at Gladstone Institutes, and the findings might help to solve some of the limitations of current immunotherapies, and identify new targets for future therapies. Read more... https://lnkd.in/dKeTGGi6 #crisprmedicinenews #crisprmedicine #geneediting #baseediting #immunesystem #crispr

A growing number of people around the world are struggling with serious diseases – including diabetes, heart disease, and cancer. Mary Helen Black (VP, Head of Human Genomics at Foresite Labs) is working at the intersection between tech and healthcare. She said: “...we now know that we can use genetic information to not only find better treatments for these diseases, but also to discern which drug is the right one to take at the right time given a person's genetic background.” Read our full interview with Black to learn more about human genomics and precision therapeutics - https://bit.ly/45mia5y #LEAP24 #techinnovation #healthtech

Happy Monday everyone! It's that time of the week again, and we have the latest news from the genomics world for you all in one place. Top stories from Week in Brief include: 🧬As part of the Human Cell Atlas, researchers have used single-cell technology to map the body’s response to COVID infection. The work explains why some individuals appear not to get the disease following exposure. 🧬Scientists have developed a low-cost, CRISPR-based test for the flu, which can be used to differentiate between different strains of the virus. 🧬Researchers have developed a new technology that can determine the precise sequence and length of telomeres on individual chromosomes. Read the full article here: https://lnkd.in/ep2fusmc

Medscape has highlighted our recent article on the importance of optimal therapy in treatment outcomes. Our research indicates that aligning treatment with comprehensive genomic profiling leads to improved health outcomes. #genomicprofiling

Unlocking the Potential of Genomics in Disease Diagnosis: Genomic testing represents a groundbreaking advancement in healthcare, allowing for the detection of genetic mutations that underlie diseases, early identification of health issues before symptoms appear, and precise classification of disease subtypes. This transformative technology enables tailored treatment strategies based on individual genetic profiles, optimizing therapeutic outcomes and patient care. Embrace the future of precision medicine and revolutionize healthcare with genomic insights. 🌍🧬 #Genomics #PrecisionMedicine #HealthcareInnovation #DiseaseDiagnosis

Molecular testing analyzes blood, tissue, or fluids to detect genes, proteins, and molecules indicative of diseases like cancer. 🧬 This powerful method helps diagnose conditions and identifies genetic changes increasing disease risk. It's integral in planning targeted treatments, monitoring response to therapy, and forecasting disease progression. You can rely on the precision of molecular testing from Clarity Labs for informed healthcare decisions. #MolecularTesting #PrecisionMedicine #ClarityLabs

Together, the Jeffrey Modell Foundation and Veritas are committed to making #genetic sequencing accessible to suspected Primary Immunodeficiency patients worldwide through the “Jeffrey's Insights” program. This collaboration spans six continents, 89 countries, 415 Jeffrey Modell Centers and 930 dedicated physicians. #PrimaryImmunodeficiency (PI) refers to a group of nearly 500 disorders of the immune system that are chronic, serious, and sometimes life-threatening. Early detection through genetic sequencing is crucial, as it can lead to life-saving interventions and #treatment strategies. However, access to genetic sequencing is challenging for many people worldwide. The alliance between the Jeffrey Modell Foundation and Veritas is more than just a partnership: it is a collaborative effort to provide #patients with proper diagnoses, treatment, and overall improved #quality of life.

The use of the Maestro MEA is becoming a standard tool for characterizing iPSC-derived cell lines in neurodegenerative disease research

Molecular testing analyzes blood, tissue, or fluids to detect genes, proteins, and molecules indicative of diseases like cancer. 🧬 This powerful method helps diagnose conditions and identifies genetic changes increasing disease risk. It's integral in planning targeted treatments, monitoring response to therapy, and forecasting disease progression. You can rely on the precision of molecular testing from Clarity Labs for informed healthcare decisions. #MolecularTesting #PrecisionMedicine #ClarityLabs